Dried blood spot (DBS) analysis has been introduced more and more into clinical practice to
facilitate Therapeutic Drug Monitoring (TDM). To assure the quality of bioanalytical methods …

Hematocrit-related issues remain a major barrier for (regulatory) acceptance of the classical
dried blood spot (DBS) analysis in the bioanalytical and clinical field. Lately, many attempts …

There is increasing interest in using dried blood spot (DBS) cards to extend the reach of
global health and disease surveillance programs to hard-to-reach populations …

Metabolomics has become an invaluable tool for both studying metabolism and biomarker
discovery. The great technical advances in analytical chemistry and bioinformatics have …

Dried blood spots (DBS) sampling and their specific advantages are becoming common in
analytical and clinical routine. Being first established for metabolic disorder screening in …

Therapeutic drug monitoring (TDM) is a specialized area of laboratory medicine which
involves the measurement of drug concentrations in biological fluids with the aim of …

Dried blood spot (DBS) sampling is recognized as a valuable alternative sampling strategy
both in research and in clinical routine. Although many advantages are associated with DBS …

Dosage adjustment of anti-epileptic drugs by therapeutic drug monitoring (TDM) is very
useful, especially for the first-generation anti-epileptic drugs (AEDs). Microsampling—the …

There is growing interest in the implementation of microsampling approaches for the
quantitation of circulating concentrations of analytes in biological samples derived from …

Opioids are well known, widely used painkillers. Increased stability of opioids in the dried
blood spot (DBS) matrix compared to blood/plasma has been described. Other benefits …